Dozens of biotechs reported earnings this week. BioSpace recaps key highlights from Capricor Therapeutics, Legend Biotech, ...
The Kansas City Business Journal brought together industry leaders to discuss the trends, pressures and innovations driving ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
AM Racing will embark on its fourth full-schedule season in the NASCAR O’Reilly Auto Parts Series in 2026 with driver Nick Sanchez competing in the full 33-race schedule ...
Nowadays, manufacturers can remotely control our vehicles, forcing us to continue paying for features even after we drive off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results